Showing results (71-80 of 244) with videos related to
Sort By:
Pageof 25
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Selective inhibition of warfarin metabolism by diltiazem in humansD R Abernethy, L S Kaminsky, T H DickinsonBritish Journal of Clinical Pharmacology|July 1, 1985
Caffeine disposition in obesityD R Abernethy, E L Todd, J B SchwartzClinical Pharmacology and Therapeutics|September 1, 1985
Lack of interaction between verapamil and cimetidineD R Abernethy, J B Schwartz, E L ToddClinical Pharmacology and Therapeutics|April 1, 1984
Plasma protein binding of drugs after severe burn injuryJ A Martyn, D R Abernethy, D J GreenblattDrug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990
Metabolite inhibition of parent drug biotransformation. Studies of diltiazemS C Tsao, T H Dickinson, D R AbernethyInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|October 1, 1985
Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugsD S Morse, D R Abernethy, D J GreenblattLife Sciences|March 7, 1998
Nitric oxide inhibits Oct-1 DNA binding activity in cultured vascular smooth muscle cellsX K Liu, D R Abernethy, N S AndrawisPharmacology|January 1, 1984
Verapamil and norverapamil determination in human plasma by gas-liquid chromatography using nitrogen-phosphorus detection: application to single-dose pharmacokinetic studiesD R Abernethy, E L Todd, J R MitchellPharmacology|January 1, 1981
Tricyclic antidepressant determination in human plasma by gas-liquid chromatography using nitrogen-phosphorous detection: application to single-dose pharmacokinetic studiesD R Abernethy, D J Greenblatt, R I ShaderClinical Pharmacokinetics|January 11, 2000
Pharmacokinetics and clinical effectiveness of methylphenidateH C Kimko, J T Cross, D R AbernethyPageof 25